2012年6月17日星期日

Off-Label Marketing Complaint Against Cephalon Survives

Allegations that Cephalon illegally marketed its pain medication called Actiq have survived a motion from the drug company requesting that the court reconsider its denial of summary judgment issued a year ago.
TheLegalIntelligencer.com

View this post on my blog: http://onlinefindlawyers.com/find-lawyers/off-label-marketing-complaint-against-cephalon-survives.html

没有评论:

发表评论